Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
Titel:
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
Auteur:
Pereira, Rosa M.R. Dagostin, Marilia A. Caparbo, Valeria F. Sales, Lucas P. Pasoto, Sandra G. Silva, Clovis A. Yuki, Emily F.N. Saad, Carla G.S. Medeiros-Ribeiro, Ana C. Kupa, Leonard V.K. Fusco, Solange R.G. Martins, Victor A.O. Martins, Carolina C.M.F. Barbas, Carmen Valente Shinjo, Samuel K. Aikawa, Nadia E. Bonfa, Eloisa